Clorox CO /DE/ Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 7.35% beneficial ownership stake in The Clorox Company.
NYSE
The Vanguard Group filed an amended Schedule 13G for Clorox Co/The, reporting 0% beneficial ownership following an internal realignment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.1% of Clorox's common stock as of June 30, 2025.
NYSE
UBS Group AG has filed an amendment to its Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in The Clorox Company as of March 31, 2025.
NYSE
UBS Group AG has disclosed a beneficial ownership of 8.15% in Clorox Co., totaling 10,084,448 shares, as of December 31, 2024, clarifying a previous administrative inclusion.
NYSE
UBS Asset Management has filed an amended Schedule 13G for The Clorox Company, correcting its reported beneficial ownership to 0.87% due to an inadvertent inclusion of positions from separate reporting entities in its initial filing.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% beneficial ownership stake in The Clorox Company's common stock as of December 31, 2024.
NYSE
UBS Group AG reports beneficial ownership of 10,794,027 shares of Clorox Co., representing an 8.7% stake.